John R. Plachetka
Keine laufenden Positionen mehr
Karriereverlauf von John R. Plachetka
Ehemalige bekannte Positionen von John R. Plachetka
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| POZEN INC. | Vorstandsvorsitzender | 01.01.1996 | 01.06.2015 |
| Vorsitzender | 01.01.1996 | 01.06.2015 | |
| Gründer | 17.06.2010 | 01.06.2015 | |
| Präsident | 01.01.1996 | 01.06.2015 | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01.01.1993 | 01.01.1995 |
| Clinical Research Foundation-America | Präsident | 01.01.1990 | 01.01.1992 |
| Glaxo, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von John R. Plachetka
| UIC College of Pharmacy | Undergraduate Degree |
| University of Missouri-Kansas City | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Kanada | 2 |
Operativ
| President | 2 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC. | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
| Clinical Research Foundation-America | |
| Glaxo, Inc. |
- Börse
- Insiders
- John R. Plachetka
- Erfahrung
